MyFinsight
Home
Blog
About
Accounts receivable, net
$6,565,400K
(17.03%↑ Y/Y)
Marketable securities
$5,538,800K
(1.19%↑ Y/Y)
Inventories
$3,084,300K
(-3.78%↓ Y/Y)
Cash and cash
equivalents
$2,455,800K
(23.05%↑ Y/Y)
Prepaid expenses and
other current assets
$801,700K
(39.60%↑ Y/Y)
Total current assets
$18,446,000K
(9.41%↑ Y/Y)
Marketable securities
$9,828,300K
(-2.29%↓ Y/Y)
Property, plant, and
equipment, net
$5,458,900K
(12.77%↑ Y/Y)
Deferred tax assets
$4,381,400K
(22.65%↑ Y/Y)
Other noncurrent
assets
$2,306,200K
(50.06%↑ Y/Y)
Intangible assets, net
$1,309,800K
(-3.10%↓ Y/Y)
Total assets
$41,730,600K
(9.19%↑ Y/Y)
Total liabilities and
stockholders' equity
$41,730,600K
(9.19%↑ Y/Y)
Total stockholders'
equity
$31,711,400K
(5.92%↑ Y/Y)
Total liabilities
$10,019,200K
(21.00%↑ Y/Y)
Treasury stock, at cost
36.4 shares in 2026...
$20,574,900K
(19.04%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$35,800K
(-168.19%↓ Y/Y)
Retained earnings
$37,621,400K
(11.70%↑ Y/Y)
Total current
liabilities
$5,530,600K
(50.82%↑ Y/Y)
Other noncurrent
liabilities
$2,281,600K
(34.06%↑ Y/Y)
Long-term debt
$1,986,600K
(0.08%↑ Y/Y)
Deferred revenue
$220,400K
(6.83%↑ Y/Y)
Additional paid-in capital
$14,700,600K
(8.97%↑ Y/Y)
Common stock-Common
Stock
$100K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$2,966,500K
(20.53%↑ Y/Y)
Accounts payable
$1,159,300K
(60.15%↑ Y/Y)
Finance lease
liabilities
$720,000K
(0.00%↑ Y/Y)
Deferred revenue
$684,800K
(42.10%↑ Y/Y)
Back
Back
Balance Sheet
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
source: myfinsight.com